beta-Cryptoxanthin, ROTICHROM® dCHR, 2 mg, Glasverpackung

2-(4-Chloro-2-fluoro-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 250mg

Messzylinder Klasse B, blau graduiert, DURAN®, hohe Form, Teilung 0,2 ml, 10 ml, 2 Stück

Hexatriacontane, 98+%, 100g

4-Bromo-2,1,3-benzothiadiazole, 95.0%, 10g

2-(Benzo[b]thiophen-2-yl)ethan-1-amine hydrochloride, 95%, 5g

8-Methyl-9H-purine, 95.0%, 1g

1-(2-Methoxybenzyl)piperidin-4-amine dihydrochloride, 95.0%, 1g

5-(4-Bromo-phenyl)-3-methyl-isoxazole-4-carboxylic acid, 95.0%, 5g

2-Amino-3-(pyridin-2-yl)propanoic acid, 95.0%, 1g

3-[4-[(tert-Butoxycarbonyl)amino]-1H-indol-1-yl]propanoic acid, 98.0%, 250mg

Vinylsulfonic Acid>97.0%(T)5g

6-oxaspiro[4.5]dec-9-ylamine hydrochloride, 95.0%, 250mg